Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

The Implications of Acetris Health for Government Contractors

Date: Thursday, October 22, 2020 12:00 PM - 1:00 PM

This year’s Federal Circuit ruling in Acetris Health, LLC v. United States fundamentally altered the Trade Agreements Act (TAA) compliance landscape – and more changes may be on the way.

Please join our webcast on Thursday, October 22 for a discussion of recent developments in this space, and the potential resulting impact on your supply chain. Topics will include:

  • What Has Changed? How does the ruling change the compliance landscape for government contractors?
  • A New Meaning for Manufacturing? What does it take to meet the manufacturing test in the U.S. and designated countries after the Acetris ruling?
  • “Substantial” Uncertainty? What changes did the decision bring to the long-held understanding of substantial transformation for drug products and what impact could it have on government procurement?
  • What’s Next? What judicial, legislative, and regulatory changes are on the horizon that could impact compliance requirements and procurement opportunities?


Jennifer Plitsch and Mike Wagner

Thursday, October 22, 2020
12 - 1 p.m. ET
9 - 10 a.m. PT

Log-in details will be provided upon registration.

Click here to register.

CLE: Approval for NY/NJ, CA, and VA CLE credit is currently pending. We will provide a Uniform Certificate of Attendance should you wish to apply in another jurisdiction.